BACKGROUND: Increased illness due to antigenically drifted A(H3N2) clade 3C.3a influenza viruses prompted concerns about vaccine effectiveness (VE) and vaccine strain selection. We used US virologic surveillance and US Influenza Vaccine Effectiveness (Flu VE) Network data to evaluate consequences of this clade. METHODS: Distribution of influenza viruses was described using virologic surveillance data. The Flu VE Network enrolled ambulatory care patients aged ≥6 months with acute respiratory illness at 5 sites. Respiratory specimens were tested for influenza by means of reverse-transcriptase polymerase chain reaction and were sequenced. Using a test-negative design, we estimated VE, comparing the odds of influenza among vaccinated versus unvaccinated participants. RESULTS: During the 2018-2019 influenza season, A(H3N2) clade 3C.3a viruses caused an increasing proportion of influenza cases. Among 2763 Flu VE Network case patients, 1325 (48%) were infected with A(H1N1)pdm09 and 1350 (49%) with A(H3N2); clade 3C.3a accounted for 977 (93%) of 1054 sequenced A(H3N2) viruses. VE was 44% (95% confidence interval, 37%-51%) against A(H1N1)pdm09 and 9% (-4% to 20%) against A(H3N2); VE was 5% (-10% to 19%) against A(H3N2) clade 3C.3a viruses. CONCLUSIONS: The predominance of A(H3N2) clade 3C.3a viruses during the latter part of the 2018-2019 season was associated with decreased VE, supporting the A(H3N2) vaccine component update for 2019-2020 northern hemisphere influenza vaccines. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
BACKGROUND: Increased illness due to antigenically drifted A(H3N2) clade 3C.3a influenza viruses prompted concerns about vaccine effectiveness (VE) and vaccine strain selection. We used US virologic surveillance and US Influenza Vaccine Effectiveness (Flu VE) Network data to evaluate consequences of this clade. METHODS: Distribution of influenza viruses was described using virologic surveillance data. The Flu VE Network enrolled ambulatory care patients aged ≥6 months with acute respiratory illness at 5 sites. Respiratory specimens were tested for influenza by means of reverse-transcriptase polymerase chain reaction and were sequenced. Using a test-negative design, we estimated VE, comparing the odds of influenza among vaccinated versus unvaccinated participants. RESULTS: During the 2018-2019 influenza season, A(H3N2) clade 3C.3a viruses caused an increasing proportion of influenza cases. Among 2763 Flu VE Network case patients, 1325 (48%) were infected with A(H1N1)pdm09 and 1350 (49%) with A(H3N2); clade 3C.3a accounted for 977 (93%) of 1054 sequenced A(H3N2) viruses. VE was 44% (95% confidence interval, 37%-51%) against A(H1N1)pdm09 and 9% (-4% to 20%) against A(H3N2); VE was 5% (-10% to 19%) against A(H3N2) clade 3C.3a viruses. CONCLUSIONS: The predominance of A(H3N2) clade 3C.3a viruses during the latter part of the 2018-2019 season was associated with decreased VE, supporting the A(H3N2) vaccine component update for 2019-2020 northern hemisphere influenza vaccines. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
Authors: Michael L Jackson; Jessie R Chung; Lisa A Jackson; C Hallie Phillips; Joyce Benoit; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard Zimmerman; Mary P Nowalk; Alicia M Fry; Brendan Flannery Journal: N Engl J Med Date: 2017-08-10 Impact factor: 91.245
Authors: Melissa A Rolfes; Brendan Flannery; Jessie R Chung; Alissa O'Halloran; Shikha Garg; Edward A Belongia; Manjusha Gaglani; Richard K Zimmerman; Michael L Jackson; Arnold S Monto; Nisha B Alden; Evan Anderson; Nancy M Bennett; Laurie Billing; Seth Eckel; Pam Daily Kirley; Ruth Lynfield; Maya L Monroe; Melanie Spencer; Nancy Spina; H Keipp Talbot; Ann Thomas; Salina M Torres; Kimberly Yousey-Hindes; James A Singleton; Manish Patel; Carrie Reed; Alicia M Fry Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 20.999
Authors: Xiyan Xu; Lenee Blanton; Anwar Isa Abd Elal; Noreen Alabi; John Barnes; Matthew Biggerstaff; Lynnette Brammer; Alicia P Budd; Erin Burns; Charisse N Cummings; Shikha Garg; Rebecca Kondor; Larisa Gubareva; Krista Kniss; Sankan Nyanseor; Alissa O'Halloran; Melissa Rolfes; Wendy Sessions; Vivien G Dugan; Alicia M Fry; David E Wentworth; James Stevens; Daniel Jernigan Journal: MMWR Morb Mortal Wkly Rep Date: 2019-06-21 Impact factor: 17.586
Authors: Brendan Flannery; Jessie R Chung; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Melissa A Rolfes; Sarah Spencer; Alicia M Fry Journal: Clin Infect Dis Date: 2019-05-17 Impact factor: 20.999
Authors: Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine Journal: J Clin Invest Date: 2021-04-15 Impact factor: 14.808
Authors: Raffael Nachbagauer; Jodi Feser; Abdollah Naficy; David I Bernstein; Jeffrey Guptill; Emmanuel B Walter; Franceso Berlanda-Scorza; Daniel Stadlbauer; Patrick C Wilson; Teresa Aydillo; Mohammad Amin Behzadi; Disha Bhavsar; Carly Bliss; Christina Capuano; Juan Manuel Carreño; Veronika Chromikova; Carine Claeys; Lynda Coughlan; Alec W Freyn; Christopher Gast; Andres Javier; Kaijun Jiang; Chiara Mariottini; Meagan McMahon; Monica McNeal; Alicia Solórzano; Shirin Strohmeier; Weina Sun; Marie Van der Wielen; Bruce L Innis; Adolfo García-Sastre; Peter Palese; Florian Krammer Journal: Nat Med Date: 2020-12-07 Impact factor: 53.440
Authors: Shinhye Kim; Erica Sy Chuang; Suzana Sabaiduc; Romy Olsha; Samantha E Kaweski; Nathan Zelyas; Jonathan B Gubbay; Agatha N Jassem; Hugues Charest; Gaston De Serres; James A Dickinson; Danuta M Skowronski Journal: Euro Surveill Date: 2022-09
Authors: Carlos G Grijalva; Leora R Feldstein; H Keipp Talbot; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Jonathan D Casey; Heidi L Erickson; Matthew C Exline; D Clark Files; Kevin W Gibbs; Adit A Ginde; Michelle N Gong; Natasha Halasa; Akram Khan; Christopher J Lindsell; Samuel K Nwosu; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay S Steingrub; William B Stubblefield; Mark W Tenforde; Manish M Patel; Wesley H Self Journal: Clin Infect Dis Date: 2021-10-20 Impact factor: 9.079
Authors: Jill M Ferdinands; Manjusha Gaglani; Shekhar Ghamande; Emily T Martin; Donald Middleton; Arnold S Monto; Fernanda Silveira; Helen K Talbot; Richard Zimmerman; Emily R Smith; Manish Patel Journal: J Infect Dis Date: 2021-07-02 Impact factor: 5.226
Authors: Jessie R Chung; Brendan Flannery; Sara S Kim; Manjusha Gaglani; Chandni Raiyani; Edward A Belongia; Huong Q McLean; Mary Patricia Nowalk; Richard K Zimmerman; Michael L Jackson; Lisa A Jackson; Emily T Martin; Arnold S Monto; Manish Patel Journal: Vaccine Date: 2021-05-13 Impact factor: 4.169
Authors: Yifei Xu; Kuiama Lewandowski; Louise O Downs; James Kavanagh; Thomas Hender; Sheila Lumley; Katie Jeffery; Dona Foster; Nicholas D Sanderson; Ali Vaughan; Marcus Morgan; Richard Vipond; Miles Carroll; Timothy Peto; Derrick Crook; A Sarah Walker; Philippa C Matthews; Steven T Pullan Journal: Euro Surveill Date: 2021-07